681465-96-3Relevant articles and documents
Terephthalamide peptidomimetic compounds and methods
-
Page/Page column 2; sheet 3, (2010/11/27)
The present invention relates to compounds and pharmaceutical compositions based upon terephthalamide which are proteomimetic and to methods for inhibiting the interaction of an alpha-helical protein with another protein or binding site. Methods for treat
Terephthalamide derivatives as mimetics of helical peptides: Disruption of the Bcl-xL/Bak interaction
Yin, Hang,Lee, Gui-In,Sedey, Kristine A.,Rodriguez, Johanna M.,Wang, Hong-Gang,Sebti, Said M.,Hamilton, Andrew D.
, p. 5463 - 5468 (2007/10/03)
A series of Bcl-xL/Bak antagonists, based on a terephthalamide scaffold, was designed to mimic the α-helical region of the Bak peptide. These molecules showed favorable in vitro activities in disrupting the Bcl-xL/Bak BH3 domain comp
Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein
Yin, Hang,Hamilton, Andrew D.
, p. 1375 - 1379 (2007/10/03)
A group of novel Bcl-xL/Bak antagonists, based on a terephthalamide scaffold, were designed to mimic the α-helical region of the Bak peptide. Good in vitro inhibition potencies in disrupting the Bak/Bcl-xL complex have been observed (terephthalamide 4, K